Get startedLog in
    Picture of Sana Biotechnology logo

    SANA — Sana Biotechnology News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    All News

    Brief: Seres Therapeutics QTRLY Loss Per Share $2.27

    Picture of Sana Biotechnology logoSana Biotechnology
    06/08/2025 14:14
    Aug 6 (Reuters) - Seres Therapeutics Inc MCRB.O:

SERES THERAPEUTICS INC: QTRLY LOSS PER SHARE $2.27

SERES THERAPEUTICS INC:  EXPECTS TO FUND OPERATIONS INTO Q1 2026

SERES THERAPEUTICS: CONTINUES TO EVALUATE COST REDUCTION ACTIONS AIMED AT EXTENDING CASH RUNWAY

Source text: ID:nGNX9qZgzt

Further company coverage: MCRB.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sana Biotechnology

    See all news